NEWS
THE WESTERN PRODUCER | WWW.PRODUCER.COM | AUGUST 23, 2012
27
RESEARCH | LICENSING
U of S reaps record research revenue Agriculture plays major role in the University of Saskatchewan’s increased licensing revenue BY DAN YATES SASKATOON NEWSROOM
The office that helps commercialize research at the University of Saskatchewan has set a new record for revenue, buoyed by the agriculture and animal production sectors. The university’s Industry Liaison Office works to patent and market research from the university’s experts, forming long-term relationships with companies along the way, said Glen Schuler of the ILO. For 2011-12, the office’s licensing revenues totalled $7.2 million, up 27 percent from the previous year, and accounts for the vast majority of the university’s total licensing revenues of $9 million. “The largest share is a circovirus vaccine for swine. That has been a very important product that we have put out,” said Schuler of a vaccine developed at the university’s Western College of Veterinary Medicine. “That has increased the amount of swine that a particular farmer then can market. That’s been something that’s been very lucrative.” A circovirus epidemic, linked to postweaning multisystemic weaning
JOHN HARDING WESTERN COLLEGE OF VETERINARY MEDICINE
syndrome in swine, was costly to producers in the early to mid 2000s. “The market for this vaccine is every single pig in the world. There’s a lot of pigs in the world and a lot being born on an annual basis. Lots of pigs and lots of vaccine sales,” said John Harding of the WCVM. Canadian researchers first identified the virus in the 1990s, and research from the WCVM, which has been commercially available since 2007, is used in the Circoflex, Circovac, Circumvent and Fostera vaccines. “All the vaccines are extremely effective. More effective than anybody, including us, would’ve imagined,” said Harding. “So there’s still a cost benefit, which is very much in favour of vaccination, and producers are still vaccinating
Research at the University of Saskatchewan’s Crop Development Centre is among the contributors to the university’s record breaking licensing revenue. | FILE PHOTO widely across the world at this point in time.” Schuler said the rest of the university’s licensing revenues comes from the Vaccine and Infectious Disease Organization and the Crop Development Centre. “They’ve got almost a couple million dollars of revenue coming in from the hybrids, the different plants they have developed through time,” said Schuler. “We find customers for the product and, ultimately, license it out. At the
end of the day, it’s not that bad a deal for the researcher, because 50 percent of the net revenue that’s earned goes back to the researcher.… The other 50 percent goes back to the university.” The ILO, established in 2004, has 45 “actively licensed technologies,” including 10 that were added last year. Schuler said more are on tap, which should help the ILO meet its target of expanding by 20 percent a year. Harding’s work also continues,
with his goal being to put research and technology into producers’ hands. He is currently studying swine dysentery. “That’s my area of research, emerging disease,” he said. “Certainly, my goal in life is to do that. (Helping) producers solve relevant problems to make them more profitable is really what it’s all about for me.” According to a news release, the 2011-12 numbers places the U of S among the top three universities in the country in licensing revenue.
Farmers have been telling us that when it comes to growing canola they are looking for more than yield. With outstanding yield potential, DEKALB brand canola hybrids also offer strong agronomics, an enhanced disease package, ease of harvest, and the superior weed control of the Genuity® Roundup Ready® system, to provide the total offering. Visit DEKALB.ca for more details.
LARRY MAZUR, DEKALB GROWER SINCE 2002 ROBLIN, MB
Monsanto Company is a member of Excellence Through Stewardship® (ETS). Monsanto products are commercialized in accordance with ETS Product Launch Stewardship Guidance, and in compliance with Monsanto’s Policy for Commercialization of Biotechnology-Derived Plant Products in Commodity Crops. This product has been approved for import into key export markets with functioning regulatory systems. Any crop or material produced from this product can only be exported to, or used, processed or sold in countries where all necessary regulatory approvals have been granted. It is a violation of national and international law to move material containing biotech traits across boundaries into nations where import is not permitted. Growers should talk to their grain handler or product purchaser to confirm their buying position for this product. Excellence Through Stewardship® is a registered trademark of Excellence Through Stewardship. ALWAYS READ AND FOLLOW PESTICIDE LABEL DIRECTIONS. Roundup Ready® crops contain genes that confer tolerance to glyphosate, the active ingredient in Roundup® brand agricultural herbicides. Roundup® brand agricultural herbicides will kill crops that are not tolerant to glyphosate. DEKALB and Design®, DEKALB®, Genuity®, Roundup Ready®, and Roundup® are registered trademarks of Monsanto Technology LLC, Monsanto Canada, Inc. licensee. ©2012 Monsanto Canada, Inc.